SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emad F. Eskander, Ahmed A. Abd-Rabou, Shaymaa M. M. Yahya, Ashraf El Sherbini, Mervat S. Mohamed, Olfat G. Shaker, “P53 Codon 72 Single Base Substitution in Viral Hepatitis C and Hepatocarcinoma Incidences”, Indian Journal of Clinical Biochemistry, 2014, 29, 1, 3

    CrossRef

  2. 2
    Jian-Yong Zou, Shao-hong Huang, Yun Li, Hui-guo Chen, Jian Rong, Sheng Ye, Airway epithelial cell-derived insulin-like growth factor-1 triggers skewed CD8+ T cell polarization, Cell Biology International, 2014, 38, 10
  3. 3
    Xiao-Feng He, Wu Wei, Zhi-Zhong Liu, Xu-Liang Shen, Xian-Bin Yang, Su-Lan Wang, Dao-Lin Xie, Association between the CYP1A1 T3801C polymorphism and risk of cancer: Evidence from 268 case–control studies, Gene, 2014, 534, 2, 324

    CrossRef

  4. 4
    Yu Lu, Yanqiong Liu, Jie Zeng, Yu He, Qiliu Peng, Yan Deng, Jian Wang, Li Xie, Taijie Li, Xue Qin, Shan Li, Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis, Tumor Biology, 2014, 35, 5, 3997

    CrossRef

  5. 5
    Yang Yang, Qi-Jun Wu, Li Xie, Wong-Ho Chow, Nat Rothman, Hong-Lan Li, Yu-Tang Gao, Wei Zheng, Xiao-Ou Shu, Yong-Bing Xiang, Prospective cohort studies of association between family history of liver cancer and risk of liver cancer, International Journal of Cancer, 2014, 135, 7
  6. 6
    Nadida Gohar, Mohamed Shehata, Dina ElAbd, Reham Zeyada, Riham Hanafy, Khaled Anbar, Mohamed El Borady, Role of p53 Arg72Pro SNP in the pathogenesis of gliomas and its effect on serum level of p53, Comparative Clinical Pathology, 2014, 23, 1, 83

    CrossRef

  7. 7
    Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu, The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases, Tumor Biology, 2014, 35, 4, 3647

    CrossRef

  8. 8
    Long Lv, Ping Wang, Xiaoqing Zhou, Beicheng Sun, Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk, Tumor Biology, 2013, 34, 3, 1451

    CrossRef

  9. 9
    Jia Huang, Yaojun Zhang, Meixian Chen, Junting Huang, Li Xu, Minshan Chen, Family history of hepatocellulcar carcinoma is not associated with its patients’ prognosis after hepatectomy, World Journal of Surgical Oncology, 2013, 11, 1, 280

    CrossRef

  10. 10
    Surong Hu, Lianying Zhao, Jingting Yang, Miao Hu, The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases, Meta Gene, 2013, 1, 126

    CrossRef

  11. 11
    Chang-Tao Xu, Fang Zheng, Xin Dai, Ji-Dong Du, Hao-Run Liu, Li Zhao, Wei-Min Li, Association Between TP53 Arg72Pro Polymorphism and Hepatocellular Carcinoma Risk: A Meta-analysis, Asian Pacific Journal of Cancer Prevention, 2012, 13, 9, 4305

    CrossRef

  12. 12
    Federica Turati, Valeria Edefonti, Renato Talamini, Monica Ferraroni, Matteo Malvezzi, Francesca Bravi, Silvia Franceschi, Maurizio Montella, Jerry Polesel, Antonella Zucchetto, Carlo La Vecchia, Eva Negri, Adriano Decarli, Family history of liver cancer and hepatocellular carcinoma, Hepatology, 2012, 55, 5
  13. 13
    Lei Yu, Lei Sun, Yang-Fang Jiang, Bao-Ling Lu, De-Rong Sun, Li-Ying Zhu, Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies, Molecular Biology Reports, 2012, 39, 6, 6641

    CrossRef

  14. 14
    Ahmet Taner Sümbül, Hikmet Akkız, Süleyman Bayram, Aynur Bekar, Ersin Akgöllü, Macit Sandıkçı, p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case–control study, Molecular Biology Reports, 2012, 39, 2, 1639

    CrossRef

  15. 15
    Woon-Puay Koh, David Van Den Berg, Aizhen Jin, Renwei Wang, Jian-Min Yuan, Mimi C. Yu, Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore, Breast Cancer Research and Treatment, 2011, 130, 3, 1011

    CrossRef

  16. 16
    Yonggang Wei, Fei Liu, Bo Li, Xi Chen, Yu Ma, Lvnan Yan, Tianfu Wen, Mingqing Xu, Wentao Wang, Jiayin Yang, Polymorphisms of Tumor Necrosis Factor-Alpha and Hepatocellular Carcinoma Risk: A HuGE Systematic Review and Meta-Analysis, Digestive Diseases and Sciences, 2011, 56, 8, 2227

    CrossRef

  17. 17
    Yone-Han Mah, Ching-Sheng Hsu, Chen-Hua Liu, Chun-Jen Liu, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan, Hepatology International, 2011, 5, 3, 814

    CrossRef

  18. 18
    Prerana Jha, Pankaj Jha, Pankaj Pathak, Kunzang Chosdol, Vaishali Suri, Mehar Chand Sharma, Guresh Kumar, Manmohan Singh, Ashok Kumar Mahapatra, Chitra Sarkar, TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3, Experimental and Molecular Pathology, 2011, 90, 2, 167

    CrossRef

  19. 19
    Peng Qi, Tong-hai Dou, Li Geng, Fei-guo Zhou, Xing Gu, Hao Wang, Chun-fang Gao, Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection, Human Immunology, 2010, 71, 6, 621

    CrossRef

  20. 20
    N Kitkumthorn, P Yanatatsaneejit, J Rabalert, C Dhammawipark, A Mutirangura, Association of P53 codon 72 polymorphism and ameloblastoma, Oral Diseases, 2010, 16, 7
  21. 21
    Tolga Acun, Ece Terzioğlu-Kara, Ozlen Konu, Mehmet Ozturk, Mustafa Cengiz Yakicier, Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010, 684, 1-2, 106

    CrossRef

  22. 22
    Jing Zhang, Wen-Lei Zhuo, Ying Zheng, Yun-Song Zhang, Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis, Medical Oncology, 2010, 27, 2, 540

    CrossRef

  23. 23
    Arshad A. Pandith, Zafar A. Shah, Nighat P. Khan, Roohi Rasool, Dil Afroze, Adfar Yousuf, Saleem Wani, Mushtaq Siddiqi, Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population, Cancer Genetics and Cytogenetics, 2010, 203, 2, 263

    CrossRef

  24. 24
    Brent C. Taylor, Jian-Min Yuan, Tatyana A. Shamliyan, Aasma Shaukat, Robert L. Kane, Timothy J. Wilt, Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence, Hepatology, 2009, 49, S5
  25. 25
    Wei-Liang Shih, Ming-Whei Yu, Pei-Jer Chen, Tai-Wei Wu, Chih-Lin Lin, Chun-Jen Liu, Shi-Ming Lin, Dar-In Tai, Shou-Dong Lee, Yun-Fan Liaw, Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study, European Journal of Human Genetics, 2009, 17, 10, 1250

    CrossRef

  26. 26
    Yoon Jun Kim, Hyo-Suk Lee, Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection, The Korean Journal of Hepatology, 2009, 15, 1, 7

    CrossRef

  27. 27
    Lessileia Gomes de Souza, Jacqueline Miranda de Lima, Ismael Dale Cotrim Guerreiro da Silva, Nora Manoukian Forones, P53 Arg72Pro Polymorphism in Gastric Cancer Patients, Journal of Gastrointestinal Cancer, 2009, 40, 1-2, 41

    CrossRef

  28. 28
    Xian-Lu Zhuo, Qi Li, Yan Zhou, Lei Cai, Zhao-Lan Xiang, Wei Yuan, Xue-Yuan Zhang, Study on TP53 Codon 72 Polymorphisms with Oral Carcinoma Susceptibility, Archives of Medical Research, 2009, 40, 7, 625

    CrossRef

  29. 29
    Xian-Lu Zhuo, Lei Cai, Zhao-Lan Xiang, Wen-Lei Zhuo, Yan Wang, Xue-Yuan Zhang, TP53 Codon 72 Polymorphism Contributes to Nasopharyngeal Cancer Susceptibility: A Meta-Analysis, Archives of Medical Research, 2009, 40, 4, 299

    CrossRef

  30. 30
    Y. J. Yoon, H. Y. Chang, S. H. Ahn, J. K. Kim, Y. K. Park, D. R. Kang, J. Y. Park, S. M. Myoung, D. Y. Kim, C. Y. Chon, K.-H. Han, MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection, Carcinogenesis, 2008, 29, 6, 1192

    CrossRef

  31. 31
    Rong-Hsing Chen, Chwen-Tzuei Chang, Tzu-Yuan Wang, Wen-Liang Huang, Chang-Hai Tsai, Fuu-Jen Tsai, p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases, Journal of Clinical Laboratory Analysis, 2008, 22, 5
  32. 32
    Ying-Chu Lin, Hsin-I Huang, Li-Hsuan Wang, Chi-Cheng Tsai, Oliver Lung, Chia-Yen Dai, Ming-Lung Yu, Chi-Kung Ho, Chung-Ho Chen, Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population, Oral Oncology, 2008, 44, 8, 798

    CrossRef

  33. 33
    Kangmin Zhu, Cynthia Moriarty, Lee S. Caplan, Robert S. Levine, Cigarette smoking and primary liver cancer: a population-based case–control study in US men, Cancer Causes & Control, 2007, 18, 3, 315

    CrossRef

  34. 34
    P. Pineau, S. Ezzikouri, A. Marchio, M. Benazzouz, E. Cordina, R. Afifi, L. Elkihal, M.T. Khalfallah, H. Mestiri, S. Tebbal, S. Berkane, N. Debzi, H. Triki, A. Dejean, F. Iguer, O. Bahri, A.E.E. Essaid el Feydi, S. Benjelloun, Genomic stability prevails in North-African hepatocellular carcinomas, Digestive and Liver Disease, 2007, 39, 7, 671

    CrossRef

  35. 35
    Maria Teresa Vietri, Gabriele Riegler, Antonietta Ursillo, Luigi Caserta, Michele Cioffi, Anna Maria Molinari, p53 codon 72 polymorphism in patients affected with ulcerative colitis, Journal of Gastroenterology, 2007, 42, 6, 456

    CrossRef

  36. 36
    Boutheina Hadhri-Guiga, Nabil Toumi, Abdelmajid Khabir, Tahia Sellami-Boudawara, Abdelmoonem Ghorbel, Jamel Daoud, Mounir Frikha, Ali Gargouri, Raja Mokdad-Gargouri, Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia, Cancer Genetics and Cytogenetics, 2007, 178, 2, 89

    CrossRef

  37. 37
    Sayeh Ezzikouri, Abdellah Essaid El feydi, Abdelaziz Chafik, Mustapha Benazzouz, Latifa El kihal, Rajae Afifi, Mohammed Hassar, Pascal Pineau, Soumaya Benjelloun, The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population, Hepatology Research, 2007, 37, 9
  38. 38
    Yun Zhai, Gangqiao Zhou, Guohong Deng, Weimin Xie, Xiaojia Dong, Xiumei Zhang, Ling Yu, Hao Yang, Xiaoyan Yuan, Hongxin Zhang, Lianteng Zhi, Zhijian Yao, Yan Shen, Boqing Qiang, Fuchu He, Estrogen Receptor α Polymorphisms Associated With Susceptibility to Hepatocellular Carcinoma in Hepatitis B Virus Carriers, Gastroenterology, 2006, 130, 7, 2001

    CrossRef

  39. 39
    Hugo Sousa, Alexandra M. Santos, Raquel Catarino, Daniela Pinto, Andre?? Vasconcelos, Carlos Lopes, Eduardo Breda, Rui Medeiros, Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development, European Journal of Cancer Prevention, 2006, 15, 4, 362

    CrossRef

  40. 40
    Elaine Cristina Morari, Andre Bacellar Costa Lima, Natassia Elena Bufalo, Janaina Luisa Leite, Fabiana Granja, Laura Sterian Ward, Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients, Journal of Cancer Research and Clinical Oncology, 2006, 132, 8, 521

    CrossRef

  41. 41
    Jang-Ming Lee, Chia-Tung Shun, Ming-Tsang Wu, Yun-Yen Chen, Shi-Yi Yang, Hsi-I Hung, Jin-Shing Chen, Hsau-Hsun Hsu, Pei-Ming Huang, Shuenn-Wen Kuo, Yung-Chie Lee, The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2006, 594, 1-2, 181

    CrossRef

  42. 42
    Zhong-Zheng Zhu, Wen-Ming Cong, Shu-Fang Liu, Zhi-Hong Xian, Wei-Qing Wu, Meng-Chao Wu, Bin Gao, Li-Fang Hou, Guan-Shan Zhu, A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection, Cancer Letters, 2005, 229, 1, 77

    CrossRef

  43. 43
    L-L Hsieh, T-H Huang, I-H Chen, C-T Liao, H-M Wang, C-H Lai, S-H Liou, J T-C Chang, A-J Cheng, p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan, British Journal of Cancer, 2005, 92, 1, 30

    CrossRef

  44. 44
    Yoon Jun Kim, Hyo-Suk Lee, Single Nucleotide Polymorphisms Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection, Intervirology, 2005, 48, 1, 10

    CrossRef

  45. 45
    Xing Li Wang, Jian Wang, Smoking-gene Interaction and Disease Development: Relevance to Pancreatic Cancer and Atherosclerosis, World Journal of Surgery, 2005, 29, 3, 344

    CrossRef

  46. 46
    M.A. Hayat, Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma, 2005,

    CrossRef

  47. 47
    Y.-c. Chen, L. Xu, Y.-l. L. Guo, H.-j. J. Su, T. J. Smith, L. M. Ryan, M.-s. Lee, D. C. Christiani, Polymorphisms inGSTT1andp53and urinary transitional cell carcinoma in south-western Taiwan: A preliminary study, Biomarkers, 2004, 9, 4-5, 386

    CrossRef

  48. 48
    Fabiana Granja, Joseane Morari, Elaine C Morari, Luiz A.C Correa, Lı́gia V.M Assumpção, Laura S Ward, Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer, Cancer Letters, 2004, 210, 2, 151

    CrossRef

  49. 49
    Regine Schneider-Stock, Carsten Boltze, Brigitte Peters, Reinhard Szibor, Olfert Landt, Frank Meyer, Albert Roessner, Selective Loss of Codon 72 Proline p53 and Frequent Mutational Inactivation of the Retained Arginine Allele in Colorectal Cancer, Neoplasia, 2004, 6, 5, 529

    CrossRef

  50. 50
    Yao-Yuan Hsieh, Chi-Chen Chang, Fuu-Jen Tsai, Cheng-Chieh Lin, Lian-Shun Yeh, Chang-Hai Tsai, Tumor necrosis factor-α-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas, Fertility and Sterility, 2004, 82, 1177

    CrossRef

  51. 51
    Nan Hu, Wen-Jun Li, Hua Su, Chaoyu Wang, A.M Goldstein, P.S Albert, M.R Emmert-Buck, Li-Hui Kong, M.J Roth, S.M Dawsey, Li-Ji He, Shu-Fen Cao, Ti Ding, Carol Giffen, P.R Taylor, Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China, Cancer Detection and Prevention, 2003, 27, 2, 132

    CrossRef

  52. 52
    Xing Li Wang, Muthuswamy Raveendran, Jian Wang, Genetic influence on cigarette-induced cardiovascular disease, Progress in Cardiovascular Diseases, 2003, 45, 5, 361

    CrossRef

  53. 53
    Yen-Ching Chen, Lilian Xu, Yu-Liang Leon Guo, Huey-Jen Jenny Su, Yu-Mei Hsueh, Thomas J. Smith, Louise M. Ryan, Meei-Shyuan Lee, Sheau-Chiou Chaor, Julia Yu-Yun Lee, David C. Christiani, Genetic Polymorphism inp53Codon 72 and Skin Cancer in Southwestern Taiwan, Journal of Environmental Science and Health, Part A, 2003, 38, 1, 201

    CrossRef

  54. 54
    George G. Chen, Juanita L. Merchant, Paul B.S. Lai, Rocky L.K. Ho, Xu Hu, Morihiro Okada, Sheng F. Huang, Albert K.K. Chui, David J. Law, Yong G. Li, Wan Y. Lau, Arthur K.C. Li, Mutation of p53 in Recurrent Hepatocellular Carcinoma and Its Association with the Expression of ZBP-89, The American Journal of Pathology, 2003, 162, 6, 1823

    CrossRef

  55. 55
    Danai Tiwawech, Petcharin Srivatanakul, Anant Karaluk, Takafumi Ishida, The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma, Cancer Letters, 2003, 198, 1, 69

    CrossRef

  56. 56
    Ming-Hsui Tsai, Chia-Der Lin, Yao-Yuan Hsieh, Florence Chi-Chen Chang, Fuu-Jen Tsai, Wen-Chi Chen, Chang-Hai Tsai, Prognostic Significance of the Proline Form of p53 Codon 72 Polymorphism in Nasopharyngeal Carcinoma, The Laryngoscope, 2002, 112, 1
  57. 57
    Chi-Chen Chang, Yao-Yuan Hsieh, Fuu-Jen Tsai, Chang-Hai Tsai, Horng-Der Tsai, Cheng-Chieh Lin, The proline form of p53 codon 72 polymorphism is associated with endometriosis, Fertility and Sterility, 2002, 77, 1, 43

    CrossRef

  58. 58
    Michael A. Kern, Kai Breuhahn, Peter Schirmacher, 2002,

    CrossRef

  59. 59
    Arndt Vogel, Susanne Kneip, Ayse Barut, Ursula Ehmer, Robert H. Tukey, Michael P. Manns, Christian P. Strassburg, Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene, Gastroenterology, 2001, 121, 5, 1136

    CrossRef

  60. 60
    M.-W. Yu, Y.-C. Yang, S.-Y. Yang, S.-W. Cheng, Y.-F. Liaw, S.-M. Lin, C.-J. Chen, Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case-Control Study Among Men, JNCI Journal of the National Cancer Institute, 2001, 93, 21, 1644

    CrossRef

  61. 61
    Jang-Ming Lee, Yung-Chie Lee, Shi-Yi Yang, Wan-Luen Shi, Chun-Jean Lee, Shi-Ping Luh, Chien-Jen Chen, Chang-Yao Hsieh, Ming-Tsang Wu, Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus, International Journal of Cancer, 2000, 89, 5
  62. 62
    Henri Bismuth, Pietro E. Majno, Hepatobiliary surgery, Journal of Hepatology, 2000, 32, 208

    CrossRef

  63. 63
    Massimiliano Bonafè, Fabiola Olivieri, Daniela Mari, Giovannella Baggio, Rosario Mattace, Maurizio Berardelli, Paolo Sansoni, Giovanna De Benedictis, Maria De Luca, Francesca Marchegiani, Luca Cavallone, Maurizio Cardelli, Simona Giovagnetti, Luigi Ferrucci, Loredana Amadio, Rosamaria Lisa, Maria Giovanna Tucci, Leonarda Troiano, Gabriella Pini, Paola Gueresi, Marina Morellini, Sandro Sorbi, Giovanni Passeri, Cristiana Barbi, Silvana Valensin, Daniela Monti, Luca Deiana, Giovanni Mario Pes, Ciriaco Carru, Claudio Franceschi, p53 Codon 72 Polymorphism and Longevity: Additional Data on Centenarians from Continental Italy and Sardinia, The American Journal of Human Genetics, 1999, 65, 6, 1782

    CrossRef